•  
logo
  • Home
  • Pharmaceutical R&D Services
    • Customized Stroke Models
      • Animal Modeling of Stroke
      • In Vitro Modeling of Stroke
    • Pathogenic Mechanism Analysis
      • Analysis of Ischemia-Triggered Glutamate Excitotoxicity
      • Molecular Mechanism Analysis of Oxidative Stress in Stroke
      • Analysis of Neuroinflammatory Mechanisms in Stroke
      • Molecular Mechanism Analysis of Ischemia-Reperfusion Injury
      • Cell Death Mechanism Analysis in Stroke
      • Epigenetic Mechanism Analysis in Stroke
      • Analysis of Gut Microbiota in Stroke
    • Stroke Drug Development Services
      • By Drug Modality
        • Small Molecule Drugs for Stroke
        • Neuropeptides
        • Monoclonal Antibodies for Stroke
        • Stem Cell-Based Therapies for Stroke
      • By Drug Action
        • Neuroprotective Agents Against Stroke
        • Thrombolytics for Stroke
        • Anticoagulant Drugs
        • Antiplatelet Drugs for Stroke
      • Customized Biospecimen Collection and Analysis Services
    • Drug Delivery System Development for Stroke
      • Nanoparticle-Based Drug Delivery Systems
      • Liposome-Based Drug Delivery Systems
      • Exosome-Based Drug Delivery Systems
      • Nasal Drug Delivery Systems
      • Virus-Based Gene Delivery Systems
    • Preclinical Evaluation Services
      • ADME/DMPK for Stroke Drugs
      • Drug Efficacy Testing for Stroke
      • Safety Assessment for Stroke Drugs
      • In Vitro Pharmacology for Stroke Drugs
    • Stroke Biomarker Development Services
      • Stroke-Related Protein Biomarkers
      • Stroke-Related RNA Biomarkers
      • Stroke-Related Metabolite Biomarkers
      • Stroke-Related Lipid Biomarkers
      • Stroke Biomarker Panels
  • Therapeutic Areas
    • Preclinical Ischemic Stroke Research Services
      • Thrombotic Stroke
      • Embolic Stroke
      • Cardioembolic Stroke
      • Cryptogenic Stroke
    • Preclinical Hemorrhagic Stroke Research Services
      • Intracerebral Hemorrhage
      • Subarachnoid Hemorrhage
    • Preclinical Transient Ischemic Attack Research Services
  • Virtual Booth
    • Brochures
    • Stroke Models
    • Case Studies
    • Protocols
  • Resources
    • Research Resources
    • Technical Notes
  • Company
    • Contact Us
    • About Us
    • Careers
Search

 

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Research Resources

  1. Home
  2. Resources
  3. Research Resources
  • Well-equipped

    In Vitro and In Vivo Models of Ischemic Stroke

  • In Vitro and In Vivo Models of Hemorrhagic Stroke

    In Vitro and In Vivo Models of Hemorrhagic Stroke

  • 3D Cortex Spheroids for Ischemic Stroke Modeling

    3D Cortex Spheroids for Ischemic Stroke Modeling

  • In Vitro Blood-Brain Barrier Models for Ischemic Stroke

    In Vitro Blood-Brain Barrier Models for Ischemic Stroke

  • P-glycoprotein Deficient Mice for Blood-Brain Barrier Studies in Stroke

    P-glycoprotein Deficient Mice for Blood-Brain Barrier Studies in Stroke

  • Porcine Stroke Models

    Porcine Stroke Models

  • What Is Stroke

    What Is Stroke

  • Injury Mechanisms in Stroke

    Injury Mechanisms in Stroke

  • Oligodendrocytes (OLs) and Ischemic Brain Injury

    Oligodendrocytes (OLs) and Ischemic Brain Injury

  • Advances in Understanding Stroke-Induced Blood-Brain Barrier Disruption: Pathophysiology and Inspection Technique

    Advances in Understanding Stroke-Induced Blood-Brain Barrier Disruption: Pathophysiology and Inspection Technique

  • The Dual Role of Hepatocyte Growth Factor in Ischemic Stroke

    The Dual Role of Hepatocyte Growth Factor in Ischemic Stroke

  • Mitochondrial Dysfunction in Ischemic Stroke

    Mitochondrial Dysfunction in Ischemic Stroke

  • Neuroinflammation in Stroke

    Neuroinflammation in Stroke

  • P-Glycoprotein Expression in the Blood–Brain Barrier After Cerebral Ischemia

    P-Glycoprotein Expression in the Blood–Brain Barrier After Cerebral Ischemia

  • RNA in Stroke Pathology, Diagnostics, and Therapeutics

    RNA in Stroke Pathology, Diagnostics, and Therapeutics

  • Glutamate Excitotoxicity in Stroke

    Glutamate Excitotoxicity in Stroke

  • Microglia in Ischemic Stroke

    Microglia in Ischemic Stroke

  • Pathological Processes of Neuronal Autophagy-Lysosome Dysfunction After Ischemic Stroke

  • The Role of Autophagy in Ischemic Stroke

  • Channels Involved in Ischemia-Mediated Neuronal Damage

  • Spreading Depolarization in Stroke

  • Current Drug Development Status for Stroke

    Current Drug Development Status for Stroke

  • Enhancing Therapy for Ischemic Stroke—Innovative Clot Busting Strategies

    Enhancing Therapy for Ischemic Stroke—Innovative Clot Busting Strategies

  • Neutrophil Extracellular Traps (NETs) Represent a New Potential Target for Stroke Treatment

    Neutrophil Extracellular Traps (NETs) Represent a New Potential Target for Stroke Treatment

  • Targeting PROTAC BET Proteins for Degradation with dBET1 Ameliorates Ischemic Stroke

    Targeting PROTAC BET Proteins for Degradation with dBET1 Ameliorates Ischemic Stroke

  • Stem Cell Therapy for Stroke

    Stem Cell Therapy for Stroke

  • Routes of Administration of Stem Cells in Stroke

    Routes of Administration of Stem Cells in Stroke

  • Boosting Neuroplasticity to Accelerate Stroke Recovery

  • Glutathione As a Potential Antioxidant for Ischemic Stroke Therapy

  • Post-stroke Neurogenesis As a Potential Target for Therapy

  • Overview of Hepatic Metabolism in Ischemic Stroke

    Overview of Hepatic Metabolism in Ischemic Stroke

  • Biomarkers in Stroke

    Biomarkers in Stroke

  • Applications of Hydrogel Scaffolds for Ischemic Stroke Therapy

    Applications of Hydrogel Scaffolds for Ischemic Stroke Therapy

  • Nanomaterials in Stroke

  • Therapeutic Potential of Intranasal Drug Delivery in Preclinical Stroke Studies

  • Behavioral Tests in Rodent Models of Stroke

    Behavioral Tests in Rodent Models of Stroke

  • High-Throughput Screening Platforms in the Discovery of Novel Drugs for Stroke

    High-Throughput Screening Platforms in the Discovery of Novel Drugs for Stroke

  • Neurotoxicity of Tissue Plasminogen Activator (tPA)

    Neurotoxicity of Tissue Plasminogen Activator (tPA)

  • Nest-building Behavior Test in Mouse Models of Stroke

    Nest-building Behavior Test in Mouse Models of Stroke

  • Ischemic Stroke In Vitro Assays

    Ischemic Stroke In Vitro Assays

  • In Vitro Testing of Novel Thrombolytics in Stroke

    In Vitro Testing of Novel Thrombolytics in Stroke

  • Open Field Test in Rodent Models of Stroke

    Open Field Test in Rodent Models of Stroke

  • Analysis of the Mechanism of Action (MoA) of Stroke Drugs

    Analysis of the Mechanism of Action (MoA) of Stroke Drugs

  • Biochemical Assays and Histological Analysis in Animal Models of Stroke

    Biochemical Assays and Histological Analysis in Animal Models of Stroke

  • The Role of Plasma Protein Binding in Drug Delivery to Brain

    The Role of Plasma Protein Binding in Drug Delivery to Brain

  • Ames Test for Genotoxicity Testing in Stroke Drug Development

    Ames Test for Genotoxicity Testing in Stroke Drug Development

  • Cognitive Tests in Rodent Models of Stroke

    Cognitive Tests in Rodent Models of Stroke

  • Techniques for Stroke Infarct Volume Measurement in Rodents

    Techniques for Stroke Infarct Volume Measurement in Rodents

  • Assessment of Hand Motor Function in NHP Models of Ischemic Stroke

    Assessment of Hand Motor Function in NHP Models of Ischemic Stroke

  • Morris Water Maze Test in Rodent Models of Stroke

    Morris Water Maze Test in Rodent Models of Stroke

  • Cytochrome P450 in Stroke

    Cytochrome P450 in Stroke

  • Cylinder Test in Rodent Models of Stroke

    Cylinder Test in Rodent Models of Stroke

  • Magnetic Resonance Imaging in Stroke

  • Assessment of Brain Penetration in Stroke Drug Discovery

  • Coronal Sections of Brain Lesion Caused by Stroke

  • Elevated-Plus Maze Test in Rodent Models of Stroke

  • RotaRod Test in Rodent Models of Stroke

  • Overview of Post-Stroke Depression

  • Overview of Anxiety After Stroke

  • The Mechanism and Treatment of Post-Stroke Pain

  • Pathophysiology and Potential Therapies of Cerebral Edema After Ischemic Stroke

  • Venous Thromboembolism After Stroke and Neutrophil Activation

  • Neuropathy After Stroke

  • Seizures and Epilepsy After Stroke

 Ace Therapeutics Preclinical CRO for Stroke

Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.

Quick Links
Home Pharmaceutical R&D Services Therapeutic Areas Resources
About us Contact us Careers
Contact Us

Copyright © 2025 Ace Therapeutics. All rights reserved.